⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Tarlatamab (AMG 757) Expanded Access Protocol for Advanced Small Cell Lung Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Tarlatamab (AMG 757) Expanded Access Protocol for Advanced Small Cell Lung Cancer

Official Title: A Phase 3b, Multicenter, Single-arm, Expanded Access Protocol of Tarlatamab (AMG 757) for the Treatment of Subjects With Advanced Small Cell Lung Cancer After Two or More Prior Lines of Treatment

Study ID: NCT06064500

Interventions

Tarlatamab

Study Description

Brief Summary: The primary objective of the study is to provide expanded access to and characterize the safety profile of tarlatamab in participants with advanced small cell lung cancer (SCLC) after two or more prior lines of treatment (including at least one platinum-based regimen).

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Yale School of Medicine, New Haven, Connecticut, United States

Mount Sinai Comprehensive Cancer Center, Miami Beach, Florida, United States

Martin Memorial Health System, Stuart, Florida, United States

Nebraska Cancer Specialists, Omaha, Nebraska, United States

Perlmutter Cancer Center at New York University Langone Hospital - 34th Street, New York, New York, United States

The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States

Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States

University of Virginia, Charlottesville, Virginia, United States

Cancer Care Northwest - South, Spokane, Washington, United States

Associacao Hospitalar Moinhos de Vento, Porto Alegre, Rio Grande Do Sul, Brazil

Sociedade Beneficente de Senhoras Hospital Sirio Libanes, Sao Paulo, São Paulo, Brazil

Okayama University Hospital, Okayama-shi, Okayama, Japan

Contact Details

Name: MD

Affiliation: Amgen

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: